SBDR - Society for Biomedical Diabetes Research

The SBDR is an international scientific society dedicated to the advancement of biomedical research to secure remission of diabetes and an improvement in patients' healthcare. The Society is committed to finding a treatment for this widespread disease that allows the cure and a most saving therapy rather than a lifelong treatment that just mitigates the syptoms. To this end, our work focuses on three major subject areas:

Diabetes News Magazine Adipose tissue in SGA individuals Adipose tissue may contribute to unbalanced leptin metabolism and reduced insulin levels... read more ROS production contributes to diabetic cardiomyopathy Clinical experience with DPP-4 inhibitors re-evaluated Family history is significant in type 2 diabetes No effect of TIP60 expres- sion on insulin secretion

• Clarification of the diabetic etiology and pathogenesis
• Re-establishing immune tolerance and restoration therapy using stem cells and gene therapy
• Improvement of patients' healthcare

The Review of Diabetic Studies is the Society's journal publishing peer-reviewed and selected research data from leading scientists. More about the journal's aims, publication principles and subscription fees can be found here.

To improve the spread of knowledge and to increase the transparency of diabetes-related research findings the SBDR supports the Diabetes Open Directory (DOD) - a global open directory project. The DOD is a growing web which serves the free spread of information and unrestricted transfer of diabetes-related knowledge. Learn more about the DOD here.

Join the SBDR and take advantage of a regular subscription of The Review of Diabetic Studies. Other benefits include reduced registration fees for topic-related conferences, and travel awards held ready for SBDR members.

SBDR membership includes:

The SBDR is a member of CrossRef. The RDS is included in DOD and PubMed.